Correlation Between EnVVeno Medical and HALLIBURTON

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both EnVVeno Medical and HALLIBURTON at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EnVVeno Medical and HALLIBURTON into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between enVVeno Medical Corp and HALLIBURTON 475 percent, you can compare the effects of market volatilities on EnVVeno Medical and HALLIBURTON and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EnVVeno Medical with a short position of HALLIBURTON. Check out your portfolio center. Please also check ongoing floating volatility patterns of EnVVeno Medical and HALLIBURTON.

Diversification Opportunities for EnVVeno Medical and HALLIBURTON

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between EnVVeno and HALLIBURTON is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding enVVeno Medical Corp and HALLIBURTON 475 percent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HALLIBURTON 475 percent and EnVVeno Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on enVVeno Medical Corp are associated (or correlated) with HALLIBURTON. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HALLIBURTON 475 percent has no effect on the direction of EnVVeno Medical i.e., EnVVeno Medical and HALLIBURTON go up and down completely randomly.

Pair Corralation between EnVVeno Medical and HALLIBURTON

Given the investment horizon of 90 days enVVeno Medical Corp is expected to under-perform the HALLIBURTON. In addition to that, EnVVeno Medical is 2.13 times more volatile than HALLIBURTON 475 percent. It trades about -0.28 of its total potential returns per unit of risk. HALLIBURTON 475 percent is currently generating about -0.1 per unit of volatility. If you would invest  9,005  in HALLIBURTON 475 percent on September 12, 2024 and sell it today you would lose (279.00) from holding HALLIBURTON 475 percent or give up 3.1% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy86.36%
ValuesDaily Returns

enVVeno Medical Corp  vs.  HALLIBURTON 475 percent

 Performance 
       Timeline  
enVVeno Medical Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days enVVeno Medical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
HALLIBURTON 475 percent 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HALLIBURTON 475 percent has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for HALLIBURTON 475 percent investors.

EnVVeno Medical and HALLIBURTON Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with EnVVeno Medical and HALLIBURTON

The main advantage of trading using opposite EnVVeno Medical and HALLIBURTON positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EnVVeno Medical position performs unexpectedly, HALLIBURTON can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HALLIBURTON will offset losses from the drop in HALLIBURTON's long position.
The idea behind enVVeno Medical Corp and HALLIBURTON 475 percent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
CEOs Directory
Screen CEOs from public companies around the world
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences